Rare diseases
Investigational molecules
Locations
Back to Spain132 clinical trials in Jaen, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study on Atezolizumab for Patients with Lung and Liver Cancer Using Digital Health Solutions
SpainStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
SpainStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
SpainStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
SpainStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
SpainStudy on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib
SpainStudy of Pembrolizumab, Carboplatin, and Paclitaxel for Patients with Metastatic Squamous Non-small Cell Lung Cancer
SpainStudy of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area
SpainStudy of Niraparib and Dostarlimab Combined with Platinum Therapy for Newly Diagnosed Stage III or IV Non-mucinous Epithelial Ovarian Cancer
SpainStudy of Nadunolimab with Gemcitabine and Carboplatin for Patients with Advanced Triple Negative Breast Cancer
SpainStudy on the Effectiveness and Safety of ALXN2220 for Adults with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
SpainStudy Comparing 7-Day and 14-Day Treatment with Vancomycin, Linezolid, and Daptomycin for Patients with Uncomplicated Enterococcal Blood Infections
SpainThe busiest research cities in the country
What the registry says about research in the country
Multiple studies focusing on non-small cell lung cancer and small cell lung cancer treatments, investigating novel combination therapies and targeted approaches for different disease stages.
Research emphasizes improving survival rates through innovative therapeutic approaches for both extensive and limited-stage disease.
Comprehensive research into HER2-positive and hormone receptor-positive breast cancer, exploring new treatment combinations and targeted therapies.
Studies focus on both early-stage and metastatic disease, with emphasis on personalized treatment approaches.
Diverse research covering hepatocellular carcinoma, bladder cancer, and other solid tumors, evaluating novel therapeutic strategies.
Investigations aim to improve treatment outcomes across multiple cancer types using cutting-edge therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
